Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) NATCO Pharma informs about press release
Date: 10-03-2023NATCO Pharma has informed that it enclosed a press release today titled ‘NATCO announces the Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the USA’.
The above information is a part of company’s filings submitted to BSE.